Purchase Order AG2349P120001

The University of Florida was awarded a definitive firm fixed price contract valued at $454,657.16 by the Department of Homeland Security Science and Technology Directorate. The scope of work is a proof-of-principle study to demonstrate the potential for human adeno-associated virus gene therapy vectors to impart sustained expression of classical swine fever virus neutralizing monoclonal antibody in pigs and protection against classical swine fever. Kansas State University and the University...

<p>This federal contract award is for the amplification and purification of adenovirus, as described in quote #WEL-172441. The contract was awarded by the Northeast Area Civilian Defense Agency to Welgen Inc., a for-profit organization, on September 15, 2017 as a firm-fixed-price purchase order. The contract has a ceiling value of $3,530.00 and a completion date of October 30, 2017. This contract does not have a set-aside designation.</p>

This is a delivery order awarded by the Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) Veterinary Services to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $26,155.95 firm-fixed-price contract is to purchase commercially available primers and probes for APHIS's ongoing African Swine Fever Virus (ASFV) and Classical Swine Fever Virus (CSFV) surveillance efforts. This delivery order is issued under an...

This firm fixed-price purchase order for $9,150.00 was awarded to DNA Twopointo Inc. (doing business as ATUM Biosciences) by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to provide other functions related to adenovirus vector construction. The award does not have a set-aside designation. DNA Twopointo Inc. is a for-profit manufacturer that has previously received federal contracts and grants from various agencies, including NIAID, the Naval Sea Systems...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Genscript USA Inc., a biotechnology company, for &quot;EXPRESS PLASMID PREPARATION, EXPRESS MUTAGENESIS TARGET AND CLONEARK PLASMID PREPARATION&quot; services. The $149,984.10 contract has a completion date of September 13, 2022 and does not have a set-aside designation. Genscript has provided similar services to support...

Genscript USA Inc. was awarded a $54,900 firm-fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to provide customized antibody and plasmid preparation services. The award is associated with a pre-solicitation notice indicating the NIAID's intent to negotiate on a sole-source basis with Genscript for 100 customized antibodies and 200 plasmid preparations to support identification of...

The U.S. government awarded a $2,656 firm fixed-price purchase order to Genscript USA Inc. for molecular biology services on July 28, 2018, with an ultimate completion date of August 15, 2018. The contract, issued by the Pacific West Area civilian agency, calls for the synthesis of a CAMV 35S promoter followed by a CTV-RB115 sequence consisting of 5,711 base pairs and the cloning of this sequence in pBluescript II SK(+) vector. The work will be performed at Genscript's facility in Piscataway,...

The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1.2 million delivery order to Utah State University, doing business as USU, under the agency's NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite-delivery/indefinite-quantity multiple award contract. The delivery order is for a new task to develop a hamster model for human adenovirus research over a three-year period ending in August...

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The $4,342.69 firm fixed-price purchase order was awarded to Genscript USA Inc., a biotechnology company based in New Jersey, for gene synthesis and plasmid preparation services. The contract did not have a set-aside designation. Genscript has received numerous prime and...

The U.S. Department of Agriculture's Agricultural Research Service (USDA ARS) awarded a $20,305 firm-fixed-price purchase order to Vectorbuilder Inc., a Chicago-based biotechnology company specializing in advanced molecular biology and gene delivery services. The contract, designated as a Total Small Business Set-Aside and awarded on March 3, 2026, requires the synthesis of five lipid nanoparticle-encapsulated self-amplifying RNA constructs based on Venezuelan equine encephalitis virus (VEEV)...